Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
56.2M
-
Number of holders
-
182
-
Total 13F shares, excl. options
-
32.5M
-
Shares change
-
+4.4M
-
Total reported value, excl. options
-
$1.14B
-
Value change
-
+$158M
-
Put/Call ratio
-
4.1
-
Number of buys
-
81
-
Number of sells
-
-83
-
Price
-
$35.20
Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q1 2017
202 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q1 2017.
REPLIGEN CORP - COMMON STOCK (RGEN) has 182 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32.5M shares
of 56.2M outstanding shares and own 57.86% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.66M shares), TimesSquare Capital Management, LLC (1.97M shares), OppenheimerFunds, Inc. (1.93M shares), VANGUARD GROUP INC (1.81M shares), Invesco Ltd. (1.61M shares), FMR LLC (1.26M shares), Conestoga Capital Advisors, LLC (1.22M shares), STATE STREET CORP (1.1M shares), DIMENSIONAL FUND ADVISORS LP (952K shares), and Ranger Investment Management, L.P. (937K shares).
This table shows the top 182 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.